What is Haemonetics's operating income?

Haemonetics (HAE) reported operating income of $67.4M in Q4 2025.

How has Haemonetics's operating income changed year-over-year?

Haemonetics's operating income increased by 14.2% year-over-year, from $59.03M to $67.4M.

What is the long-term trend for Haemonetics's operating income?

Over 3 years (2022 to 2025), Haemonetics's operating income has grown at a 40.1% compound annual growth rate (CAGR), from $80.75M to $221.82M.

What does operating income mean?

Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Haemonetics HAE Operating Income

Operating Income at other companies

AbbottABT

$1.35B-20.6%

TFX

TeleflexTFX

$20.18M-73.4%

Boston ScientificBSX

$1.1B+19.5%

MedtronicMDT

$1.87B+30.4%

LivaNovaLIVN

$41.47M-14.7%

ICU MedicalICUI

$13.58M+5.4%

Segments

By segment

See full

Plasma$43.69M-13.7%

Hospital$29.57M+35.7%

Blood Center$11.24M+13.3%

Other financials

Income statement

See full

Revenue$346.4M+4.8%

Gross profit$198.2M+2.7%

Net income$44.7M+19.3%

EPS (diluted)$0.95+28.4%

Balance sheet

See full

Cash & equivalents$245.4M-20.0%

Total debt$1.3B-0.7%

Total equity$796.3M-3.0%

Total assets$2.4B-2.2%

Cash flow

See full

Operating cash flow$70.9M-39.1%

CapEx$17.7M+12.9%

Free cash flow$53.3M-47.2%

Valuation

See full

Market cap$3.37B-18.0%

Enterprise value$4.4B-12.5%

P/S2.5×-0.5×

Profitability

See full

Gross margin59%+4.0pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin19.5%+9.1pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.6×0.0×

Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Haemonetics's operating income?: Haemonetics (HAE) reported operating income of $67.4M in Q4 2025.
How has Haemonetics's operating income changed year-over-year?: Haemonetics's operating income increased by 14.2% year-over-year, from $59.03M to $67.4M.
What is the long-term trend for Haemonetics's operating income?: Over 3 years (2022 to 2025), Haemonetics's operating income has grown at a 40.1% compound annual growth rate (CAGR), from $80.75M to $221.82M.
What does operating income mean?: Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.